Erin Catherine Carter serves as Executive at Glucotrack, Inc., where they oversee executive responsibilities. Since joining the company, Erin Catherine Carter has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 3, 2025 involved receiving (via award) 386 shares valued at $0.
Erin Catherine Carter currently holds 2,148 shares of Glucotrack, Inc. (GCTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin Catherine Carter has been a net neutral trader of GCTK stock. They have purchased $0 and sold $0 worth of shares.
Erin Catherine Carter's most recent insider trade was on Oct 3, 2025, when they sold 386 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 25, 2025 | GCTK | $0 | Award | 32 | $N/A | Discretionary |